<DOC>
	<DOCNO>NCT00744874</DOCNO>
	<brief_summary>The purpose trial investigate confirm safety , efficacy , efficiency Ablation Frontiers® Cardiac Ablation System use treatment paroxysmal atrial fibrillation . ( PAF )</brief_summary>
	<brief_title>Ablation Pulmonary Veins Paroxysmal Afib</brief_title>
	<detailed_description>This trial non-randomized , multi-center , prospective study subject symptomatic , paroxysmal atrial fibrillation ( PAF ) . The purpose study investigate confirm safety , efficacy efficiency Medtronic Ablation Frontiers® Cardiac Ablation System use treatment paroxysmal AF . The trial conduct 2 year period enrollment occur 4 October 2007 1 December 2008 .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>History symptomatic paroxysmal atrial fibrillation define : Self terminate AF last 7 day AF event demostrating spontaneous conversion back sinus rhythm Documentation one event PAF tracing ECG , event recording , pacemaker strip monitor rhythm strip within past year AF symptom define manisfestation following : Palpitations , Fatigue , Exertional dyspnea , effort intolerance Age 18 70 Willingness , ability commitment participate baseline followup evaluation full length study Structural heart disease clinical significance Prior ablation arrhythmia AF within past three month Prior leave sided AF ablation Enrollment ongoing arrhythmia study protocol Any ventricular tachyarrhythmias currently treat arrhythmia management may interfere study Active infection sepsis Any history cerebral vascular disease include stroke TIAs Pregnancy lactation Untreatable allergy contrast medium Any diagnosis atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiovascular cause History blood clotting ( bleed thrombotic ) abnormalities Known sensitivity heparin warfarin Severe COPD ( identify FEV1 &lt; 1 ) Severe co morbidity poor general physical/mental health , opinion investigator , allow patient good study candidate ( i.e . disease process , mental capacity , substance abuse , shorten life expectance , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>atrial fibrillation</keyword>
</DOC>